Potential target for therapy for patients with a deadly prostate cancer
Monday, November 8, 2010 - 19:30
in Health & Medicine
A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy, according to a new study.